急性胰腺炎(AP)是一种急性、全身消耗性的危重疾病,是胰酶在胰腺内被激活后引起胰腺组织自身消化的化学性炎症,临床分为轻症急性胰腺炎(MAP)和重症急性胰腺炎(SAP)。根据亚特兰大会议制定的标准,75%的胰腺炎病人为轻型胰腺炎,病死率<1%,而重症坏死型胰腺炎病死率约为20%,最严重者甚至可达30%～40%。关于SAP的治疗,20世纪90年代后,药物治疗有了许多新的近展,但其最基本的治 Acute pancreatitis (AP) is an acute and systemic consumptive disease. It is a chemical inflammation that causes pancreatic tissue to digest itself after it is activated in pancreas. It is divided into mild acute pancreatitis (MAP) and severe disease Acute pancreatitis (SAP). According to criteria set by the Atlanta conference, 75% of patients with pancreatitis have mild pancreatitis with a mortality rate of <1%, while those with severe necrotizing pancreatitis have a mortality rate of about 20% and even the worst with 30% to 40%. With regard to the treatment of SAP, since the 1990s, there have been many new recent advances in medical treatment, but its most basic treatment